IL164814A0 - Preparations for topical administration of substances having antiandrogenic activity - Google Patents

Preparations for topical administration of substances having antiandrogenic activity

Info

Publication number
IL164814A0
IL164814A0 IL16481404A IL16481404A IL164814A0 IL 164814 A0 IL164814 A0 IL 164814A0 IL 16481404 A IL16481404 A IL 16481404A IL 16481404 A IL16481404 A IL 16481404A IL 164814 A0 IL164814 A0 IL 164814A0
Authority
IL
Israel
Prior art keywords
preparations
substances
topical administration
antiandrogenic activity
antiandrogenic
Prior art date
Application number
IL16481404A
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL164814A0 publication Critical patent/IL164814A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16481404A 2002-04-27 2004-10-25 Preparations for topical administration of substances having antiandrogenic activity IL164814A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10218963A DE10218963A1 (en) 2002-04-27 2002-04-27 Preparations for the topical application of antiandrogen active substances
PCT/EP2003/003837 WO2003093243A1 (en) 2002-04-27 2003-04-14 Preparations for the topical application of anti-androgenically active substances

Publications (1)

Publication Number Publication Date
IL164814A0 true IL164814A0 (en) 2005-12-18

Family

ID=29264882

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16481404A IL164814A0 (en) 2002-04-27 2004-10-25 Preparations for topical administration of substances having antiandrogenic activity

Country Status (17)

Country Link
EP (1) EP1501806B1 (en)
JP (1) JP4633459B2 (en)
AR (1) AR039662A1 (en)
AT (1) ATE321756T1 (en)
AU (1) AU2003229658B2 (en)
BR (1) BRPI0309579B8 (en)
CA (1) CA2483786C (en)
DE (2) DE10218963A1 (en)
DK (1) DK1501806T3 (en)
ES (1) ES2256735T3 (en)
IL (1) IL164814A0 (en)
MX (1) MXPA04009571A (en)
MY (1) MY129714A (en)
PE (1) PE20031044A1 (en)
PT (1) PT1501806E (en)
TW (1) TWI285637B (en)
WO (1) WO2003093243A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1634874A4 (en) 2003-06-12 2008-04-02 Chugai Pharmaceutical Co Ltd Imidazolidine derivative
US8034548B2 (en) 2003-12-19 2011-10-11 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
KR100783255B1 (en) 2004-02-13 2007-12-06 워너-램버트 캄파니 엘엘씨 Androgen receptor modulators
CN100475781C (en) * 2004-02-13 2009-04-08 沃尼尔·朗伯有限责任公司 Androgen receptor modulators
AU2005232526B2 (en) 2004-02-24 2011-06-23 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7507860B2 (en) 2004-04-13 2009-03-24 Pfizer Inc. Androgen modulators
BRPI0509980A (en) 2004-04-22 2007-10-16 Warner Lambert Co androgen modulators
MXPA06015169A (en) 2004-07-08 2007-08-21 Warner Lambert Co Androgen modulators.
ES2302229T3 (en) * 2004-08-31 2008-07-01 Warner-Lambert Company Llc ANDROGEN MODULATORS.
TW200724139A (en) * 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
HUE032085T2 (en) 2006-03-27 2017-09-28 Univ California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
JP5350217B2 (en) 2006-03-29 2013-11-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Diarylthiohydantoin compounds
TW201716385A (en) 2007-10-26 2017-05-16 加州大學董事會 Diarylhydantoin compounds
EP3124481B1 (en) 2010-02-16 2018-03-28 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
RU2503446C2 (en) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Hair growth product (versions) and methods of treating alopecia
SI3305285T1 (en) 2012-09-26 2021-03-31 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL222631B1 (en) * 2012-11-14 2016-08-31 Gdański Univ Medyczny Pharmaceutical composition comprising Roxithromycin, method for manufacture and medical use of the composition and the medicinal product comprising a composition
WO2014078929A1 (en) * 2012-11-26 2014-05-30 Universidade Federal De Minas Gerais - Ufmg Topical formulation for the prevention and treatment of alopecia and for inhibiting hair growth
JOP20200097A1 (en) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc Androgen receptor modulator and uses thereof
CN103965112A (en) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 Compound with antiandrogen activity as well as preparation method and application of compound
TWI726969B (en) 2016-01-11 2021-05-11 比利時商健生藥品公司 Substituted thiohydantoin derivatives as androgen receptor antagonists
JOP20200076A1 (en) 2017-10-16 2020-04-30 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (en) * 1992-07-08 1994-09-02 Roussel Uclaf New substituted phenylimidazolidines, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2716110B1 (en) * 1994-02-16 1996-04-05 Roussel Uclaf Cosmetic or pharmaceutical compositions comprising liposomes.
AU726572B2 (en) * 1994-02-16 2000-11-09 Aventis Pharma S.A. Cosmetics or pharmaceutical compositions consisting of liposomes

Also Published As

Publication number Publication date
TW200407312A (en) 2004-05-16
DE50302818D1 (en) 2006-05-18
EP1501806A1 (en) 2005-02-02
AU2003229658B2 (en) 2010-07-29
WO2003093243A1 (en) 2003-11-13
JP4633459B2 (en) 2011-02-16
EP1501806B1 (en) 2006-03-29
CA2483786A1 (en) 2003-11-13
DK1501806T3 (en) 2006-05-29
AU2003229658A1 (en) 2003-11-17
ATE321756T1 (en) 2006-04-15
PE20031044A1 (en) 2004-02-09
BR0309579A (en) 2005-03-01
PT1501806E (en) 2006-06-30
TWI285637B (en) 2007-08-21
MXPA04009571A (en) 2005-01-11
DE10218963A1 (en) 2003-11-20
CA2483786C (en) 2011-08-09
BR0309579B1 (en) 2014-10-07
ES2256735T3 (en) 2006-07-16
JP2005535584A (en) 2005-11-24
BRPI0309579B8 (en) 2021-05-25
MY129714A (en) 2007-04-30
AR039662A1 (en) 2005-03-02

Similar Documents

Publication Publication Date Title
IL164814A0 (en) Preparations for topical administration of substances having antiandrogenic activity
AU2003257666A1 (en) COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
AU2003264427A1 (en) Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
HUP0401923A3 (en) New urea derivatives having pharmacological activity and pharmaceutical compositions containing them
HU0103988D0 (en) New compounds with pharmaceutical activity
HU0004123D0 (en) New compounds with pharmaceutical activity
HU0103987D0 (en) New compounds with pharmaceutical activity
HK1068812A1 (en) Drug preparations
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003265225A1 (en) Preparations for topical skin use and treatment
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
EP1465656A4 (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION
AU2003222786A1 (en) Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
IL146449A0 (en) Method and pharmaceutical preparations for reducing the activity of cells
AU2002366799A1 (en) Allantoin-containing preparations for administration as gels and aerosols
EP1475095A4 (en) Percutaneous preparations
HU9802716D0 (en) Pharmaceutical composition of analgesic activity
AU2001248943A1 (en) Pharmaceutical curative compound
AU2002328000A1 (en) Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
AU2003201853A1 (en) Skin preparations for external use
GB9902227D0 (en) Pharmaceutical composition for topical administration
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed